297 related articles for article (PubMed ID: 27766950)
1. Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia.
Karim S; Al-Maghrabi JA; Farsi HM; Al-Sayyad AJ; Schulten HJ; Buhmeida A; Mirza Z; Al-Boogmi AA; Ashgan FT; Shabaad MM; NourEldin HF; Al-Ghamdi KB; Abuzenadah A; Chaudhary AG; Al-Qahtani MH
BMC Cancer; 2016 Sep; 16(Suppl 2):741. PubMed ID: 27766950
[TBL] [Abstract][Full Text] [Related]
2. Low level of Cyclin-D1 correlates with worse prognosis of clear cell renal cell carcinoma patients.
Wang QS; Li F; Liao ZQ; Li K; Yang XL; Lin YY; Zhao YL; Weng SY; Xia Y; Ye Y; Li SH; Wang CY; Lin Y
Cancer Med; 2019 Aug; 8(9):4100-4109. PubMed ID: 31183974
[TBL] [Abstract][Full Text] [Related]
3. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
4. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
[TBL] [Abstract][Full Text] [Related]
5. WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.
Hsu RJ; Ho JY; Cha TL; Yu DS; Wu CL; Huang WP; Chu P; Chen YH; Chen JT; Yu CP
PLoS One; 2012; 7(10):e47649. PubMed ID: 23094073
[TBL] [Abstract][Full Text] [Related]
6. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
7. LINC01510 suppresses cell proliferation and invasion by inhibiting Wnt/β-catenin signaling in renal cell carcinoma.
Ma B; Zhang J; Zhou W; Chu C; Zhao C; Zhang Z; Huang T
Biochem Biophys Res Commun; 2018 Oct; 505(1):7-12. PubMed ID: 30224058
[TBL] [Abstract][Full Text] [Related]
8. Impact of S100A8 expression on kidney cancer progression and molecular docking studies for kidney cancer therapeutics.
Mirza Z; Schulten HJ; Farsi HM; Al-Maghrabi JA; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH; Karim S
Anticancer Res; 2014 Apr; 34(4):1873-84. PubMed ID: 24692722
[TBL] [Abstract][Full Text] [Related]
9. High expression of fructose-bisphosphate aldolase A induces progression of renal cell carcinoma.
Huang Z; Hua Y; Tian Y; Qin C; Qian J; Bao M; Liu Y; Wang S; Cao Q; Ju X; Wang Z; Gu M
Oncol Rep; 2018 Jun; 39(6):2996-3006. PubMed ID: 29693182
[TBL] [Abstract][Full Text] [Related]
10. Microarray gene expression profiling and analysis in renal cell carcinoma.
Liou LS; Shi T; Duan ZH; Sadhukhan P; Der SD; Novick AA; Hissong J; Skacel M; Almasan A; DiDonato JA
BMC Urol; 2004 Jun; 4():9. PubMed ID: 15212686
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of the synergy of 5-aza-2'-deoxycytidine and paclitaxel against renal cell carcinoma.
Han T; Shang D; Xu X; Tian Y
World J Surg Oncol; 2012 Sep; 10():183. PubMed ID: 22950635
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of cyclin D1 in renal cell carcinoma.
Lima MS; Pereira RA; Costa RS; Tucci S; Dantas M; Muglia VF; Ravinal RC; Barros-Silva GE
Int Urol Nephrol; 2014 May; 46(5):905-13. PubMed ID: 24242739
[TBL] [Abstract][Full Text] [Related]
14. Network spatio-temporal analysis predicts disease stage-related genes and pathways in renal cell carcinoma.
Li1 XH; Yang CZ; Wang J
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173324
[TBL] [Abstract][Full Text] [Related]
15. Screening, identification and validation of CCND1 and PECAM1/CD31 for predicting prognosis in renal cell carcinoma patients.
Yang JF; Shi SN; Xu WH; Qiu YH; Zheng JZ; Yu K; Song XY; Li F; Wang Y; Wang R; Qu YY; Zhang HL; Zhou XQ
Aging (Albany NY); 2019 Dec; 11(24):12057-12079. PubMed ID: 31850854
[TBL] [Abstract][Full Text] [Related]
16. CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma.
Sukov WR; Ketterling RP; Lager DJ; Carlson AW; Sinnwell JP; Chow GK; Jenkins RB; Cheville JC
Hum Pathol; 2009 Sep; 40(9):1296-303. PubMed ID: 19386349
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 and p57 expression in relation to clinicopathological characteristics and overall survival in patients with renal cell carcinoma.
Latic D; Pejic S; Savic S; Loncar Z; M Nikolic I; Nikolic G; Pavlovic I; Radojevic-Skodric S
J BUON; 2019; 24(1):301-309. PubMed ID: 30941985
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
[TBL] [Abstract][Full Text] [Related]
19. The kinesin motor protein KIF4A as a potential therapeutic target in renal cell carcinoma.
Liu G; Lu Y; Li L; Jiang T; Chu S; Hou P; Bai J; Chen M
Invest New Drugs; 2020 Dec; 38(6):1730-1742. PubMed ID: 32533288
[TBL] [Abstract][Full Text] [Related]
20. Expression profiling based graph-clustering approach to determine renal carcinoma related pathway in response to kidney cancer.
Lou S; Ren L; Xiao J; Ding Q; Zhang W
Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):775-80. PubMed ID: 22913210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
